Century Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Century Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
  • Century Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -66.6 %, a 35.1% decline year-over-year.
  • Century Therapeutics, Inc. annual Return On Equity for 2023 was -58.9 %, a 54.8% decline from 2022.
  • Century Therapeutics, Inc. annual Return On Equity for 2022 was -38 %, a 16.6% decline from 2021.
  • Century Therapeutics, Inc. annual Return On Equity for 2021 was -32.6 %, a 169% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -66.6 -17.3 -35.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -65.4 -21.5 -49% Apr 1, 2024 Jun 30, 2024
Q1 2024 -64.4 -25 -63.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -58.9 -20.9 -54.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -49.3 -14.6 -42.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -43.9 -12.5 -39.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -39.3 -11.5 -41.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -38 -5.41 -16.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -34.7 +14.8 +29.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -31.4 +202 +86.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -27.8 -83.9 -150% Jan 1, 2022 Mar 31, 2022
Q4 2021 -32.6 -79.9 -169% Oct 1, 2021 Dec 31, 2021
Q3 2021 -49.5 Jul 1, 2021 Sep 30, 2021
Q2 2021 -233 Apr 1, 2021 Jun 30, 2021
Q1 2021 56.1 Jan 1, 2021 Mar 31, 2021
Q4 2020 47.3 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.